PGT-SR

About Genomic Prediction

Genomic Prediction is a private, commercial-stage company providing sophisticated genetic screening services for the fertility market. Its core innovation is the application of polygenic risk scores (PRS) to embryo selection, moving beyond traditional PGT to assess risk for common diseases like diabetes, heart disease, and cancer. The company's business model is service-based, partnering with fertility clinics and offering tests directly to patients. While generating revenue, it faces significant regulatory, ethical, and market adoption challenges in a competitive landscape.

About Luminary Genetics

Luminary Genetics is a private, commercial-stage provider of reproductive genetic testing services, operating within the rapidly growing fertility and genomics sectors. The company offers a suite of validated tests including PGT-A, PGT-SR, PGT-M, and POC testing, utilizing a proprietary NGS platform to ensure high precision for IVF patients. As part of the larger Luminary Life Sciences family, it benefits from an integrated ecosystem of fertility services. The company is led by a seasoned team with decades of collective experience and is positioned to capitalize on technological advances and increasing demand for genetic screening in assisted reproduction.

Therapeutic Areas